Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Enalapril + lercanidipine versus enalapril + amlodipine for proteinuria in chronic kidney disease with hypertension
2013-001394-25Phase 4Completed
- Sponsor
- Universidad de Salamanca
- Start
- Jun 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in chronic kidney disease (CKD), hypertension (HTN) and proteinuria comparing Enalapril + lercanidipine with Enalapril + amlodipine (2 arms). Primary endpoint: Changes in renal function. Started Jun 2013; status: completed.
02
Drugs
enalaprillercanidipineamlodipine
03
Conditions
chronic kidney disease (CKD)hypertension (HTN)proteinuria
Beyond the preview
Go deeper on 2013-001394-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-001394-25.